2
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Vasoactive Drugs in Treatment of Shock

, M.D.
Pages 105-109 | Published online: 18 Apr 2016

REFERENCES

  • Ahlquist, R. P.: A study of adrenotropic receptors. Amer J Physiol 153:586, 1948.
  • Hershey, S. G., Mazzia, V. D., Altura, B. M. and Gyure, L: Effects of vasopressors on the microcirculation and on survival in hemorrhagic shock. Anesthesiology 26:179, 1965.
  • Rosenberg, J. C., Lillehei, R. G, Longerbeam, J. K. and Zimmerman, B.: Studies on hemorrhagic and endotoxin shock in relation to vasomotor changes and endogenous circulating epinephrine, norepinephrine and serotonin. Ann Surg 154:611, 1961.
  • Erlanger, J. and Gasser, H. S.: Studies in secondary traumatic shock. III. Circulatory failure due to adrenaline. Amer J Physiol 49:345, 1919.
  • Yard, A. and Nickerson, M.: Shock produced in dogs by infusion of norepinephrine. Fed Proc 15: 502, 1956.
  • Fitts, C. T. and Sawyer, R. B.: The use of drugs in treatment of irreversible vasoconstrictor shock. J Trauma 5:11, 1965.
  • Nickerson, M. and Carter, S. A.: Protection against acute trauma and traumatic shock by vasodilators. Canad J Biochem 37:1161, 1959.
  • Nickerson, M. and Gourzis, J. T.: Blockade of sympathetic vasoconstriction in the treatment of shock. J Trauma 2:399, 1962.
  • Nickerson, M.: Sympathetic blockade in the therapy of shock. Amer J Cardiol 12:919, 1963.
  • Baue, A. E., Johnson, D. G. and Parkins, W. M.: Blood flow and oxygen consumption with adrenergic blockade in hemorrhagic shock. Amer J Physiol 211:354, 1966.
  • Lillehei, R. C., Longerbeam, J. K., Bloch, J. H. and Manax, W. G.: The nature of irreversible shock. Ann Surg 160:682, 1964.
  • Rush, B. F., Jr., Rosenberg, J. C. and Spencer, F. C.: Effect of Dibenzyline treatment on cardiac dynamics and oxidative metabolism in hemorrhagic shock. Ann Surg 162:1013, 1965.
  • Baue, A. E., Jones, E. F. and Parkins, W. M.: The effects of beta-adrenergic receptor stimulation on blood flow, oxidative metabolism and survival in hemorrhagic shock. Ann Surg 167:403, 1968.
  • Appel, A. J., Lintermans, J. P., Mullins, G. L. and Guntheroth, W. G.: The effects of vasoactive drugs on mesenteric blood flow and volume. Surg Gynec Obstet 123:755, 1966.
  • Johnson, D. G. and Parkins, W. M.: Effects of isoproterenol and levarterenol on blood flow and oxygen use in hemorrhagic shock. Arch Surg 92: 277, 1966.
  • MacLean, L. D., Duff, J. H., Scott, H. M. and Peretz, D. I.: Treatment of shock in man based on hemodynamic diagnosis. Surg Gynec Obstet 120:1, 1965.
  • Brown, R. S. et al.: Comparative evaluation of sympathomimetic amines in clinical shock. Circulation 34:260, 1966.
  • Siegel, J. H. and Fabian, M.: Therapeutic advantages of an inotropic vasodilator in endotoxin shock. JAMA 200:696, 1967.
  • Kardos, G. G.: Isoproterenol in the treatment of shock due to bacteremia with gram-negative pathogens. New Eng J Med 274:868, 1966.
  • Siegel, J. H., Greenspan, M. and Del Guercio, L. R.: Abnormal vascular tone, defective oxygen transport and myocardial failure in human septic shock. Ann Surg 165:504, 1967.
  • Wilson, J. N.: Rational approach to management of clinical shock. Arch Surg 91:92, 1965.
  • Gunnar, R. M. et al.: Ineffectiveness of isoproterenol in shock due to acute myocardial infarction. JAMA 202:1124, 1967.
  • Webb, W. R.: Clinical guides in shock. Med Times 89:1271, 1961.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.